(1) The commission identifies the following as an over-the-counter drug in Washington:
(a) 4 mg naloxone hydrochloride nasal spray, approved by the FDA for marketing as an OTC drug product.
(b) 3 mg naloxone hydrochloride nasal spray, approved by the FDA for marketing as an OTC drug product.
(2) Any conflicts between this section and the publications incorporated by reference in WAC
246-945-030(2) should be resolved in favor of this section.